By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...

Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

Having multiple treatment options is the kind of advancement we’ve all been ... research that showed physical changes that happen in the brain due to Alzheimer’s disease. "Defining diseases by the ...

A groundbreaking discovery by scientists at Japan’s RIKEN Center for Brain Science has revealed an unexpected link between dopamine and Alzheimer’s disease ... s treatment stems from its ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

The treatment is not a permanent fix for Alzheimer's dementia, Jing said, because the disease will eventually ... It's important for them to know there are options out there." ...

Having multiple treatment options is the kind of advancement ... showed physical changes that happen in the brain due to Alzheimer’s disease. “Defining diseases by the biology has long been ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

Targeting toxic oligomers without binding to plaque, designed to reduce the risk of ARIA and potentially deliver enhanced ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

Posdinemab works by targeting and neutralizing Alzheimer disease-specific phosphorylated tau, preventing its spread to other neurons.

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment of Early Alzheimer’s Disease: Results from the ...